WuXi AppTec Co., Ltd.

Research WuXi AppTec Co., Ltd. (603259.SS) on Bullrun: market cap CNY 437.94B, P/E 19.6, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CNY 437.94B; P/E is 19.6; dividend yield is 1.4%.

Peer valuation comparison

Latest P/E is 19.55x versus a Healthcare sector median of 21.69x (9.9% below).

Latest dividend yield is 1.41% versus a Healthcare sector median of 2.41% (41.5% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18CNY 437.94B19.61.5%2.09

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2.09 CNY, yield 1.4%.

About WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments.

ETFs that hold WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd. is one of the ten largest holdings of 2 ETFs that investors in Europe can buy, most traded first:

Related stock research

Other Healthcare stocks

Frequently asked questions

What is WuXi AppTec Co., Ltd.'s market cap?

WuXi AppTec Co., Ltd.'s market capitalization is CNY 437.94B.

What is WuXi AppTec Co., Ltd.'s P/E ratio?

WuXi AppTec Co., Ltd.'s price-to-earnings (P/E) ratio is 19.6.

Does WuXi AppTec Co., Ltd. pay a dividend?

WuXi AppTec Co., Ltd. has a dividend yield of 1.4%.

What does WuXi AppTec Co., Ltd. do?

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments.